Vexim strengthens its management structure with the appointment of Jérôme Marzinski as Deputy CEO
Toulouse, October 9th 2013 - VEXIM (FR0011072602 - ALVXM), a medical device company specializing in the minimally-invasive treatment of vertebral fractures, today announced that Jérôme Marzinski will take up the position of Deputy CEO, as the company continues to show steady growth. Jérôme will contribute to bringing Vexim into its next phase of development, reporting to the CEO, Vincent Gardès.
Jérôme Marzinski is 40 years old and joins VEXIM as Deputy CEO. Jérôme has a financial background, having obtained a Masters in Finance from the University of Lille (1994) and an MBA from the HEC Business School in Paris (2012). Jérôme began his career as a financial analyst at SGI (1995–1997), then as Finance Manager with Hertz (1998–1999). Following that, he joined Sun Microsystems Inc., where he took up management positions from 2000 to 2007, in the United States, France, the United Kingdom and the Netherlands. In 2007, he became fully immersed in the domain of medical technologies when he joined ev3, a company specialising in vascular implants, as International Finance Manager and then as Europe GM, from 2009 to 2012, participating in the buyout of ev3 by the American group Covidien in 2010. Before joining Vexim in August 2013, Jérôme successfully carried out executive consulting missions for medtech companies’ managers and shareholders. He has a deep understanding of the business and has strong financial and operational knowledge of the constraints and the stakes at play in the medical device sector. Jérôme’s financial and managerial skills will allow him to support Vexim’s strong growth.
Posted: October 2013